JP2016518452A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016518452A5 JP2016518452A5 JP2016514093A JP2016514093A JP2016518452A5 JP 2016518452 A5 JP2016518452 A5 JP 2016518452A5 JP 2016514093 A JP2016514093 A JP 2016514093A JP 2016514093 A JP2016514093 A JP 2016514093A JP 2016518452 A5 JP2016518452 A5 JP 2016518452A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- item
- composition according
- salt
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361823766P | 2013-05-15 | 2013-05-15 | |
| US61/823,766 | 2013-05-15 | ||
| PCT/US2014/038211 WO2014186581A1 (en) | 2013-05-15 | 2014-05-15 | Cenicriviroc compositions and methods of making and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016518452A JP2016518452A (ja) | 2016-06-23 |
| JP2016518452A5 true JP2016518452A5 (https=) | 2017-06-08 |
| JP6391674B2 JP6391674B2 (ja) | 2018-09-19 |
Family
ID=51898872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016514093A Expired - Fee Related JP6391674B2 (ja) | 2013-05-15 | 2014-05-15 | セニクリビロック組成物並びにその製造及び使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20160081985A1 (https=) |
| EP (1) | EP2996694A4 (https=) |
| JP (1) | JP6391674B2 (https=) |
| KR (1) | KR20160013068A (https=) |
| CN (1) | CN105263498B (https=) |
| AU (1) | AU2014265327B2 (https=) |
| BR (1) | BR112015028644A2 (https=) |
| CA (1) | CA2911212A1 (https=) |
| CL (1) | CL2015003346A1 (https=) |
| IL (1) | IL242394B (https=) |
| MX (1) | MX383706B (https=) |
| MY (1) | MY180145A (https=) |
| PH (1) | PH12015502539A1 (https=) |
| RU (1) | RU2633069C2 (https=) |
| SG (2) | SG10201708595YA (https=) |
| UA (1) | UA115807C2 (https=) |
| WO (1) | WO2014186581A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20030329A1 (es) | 2001-08-08 | 2003-05-12 | Takeda Chemical Industries Ltd | Compuesto biciclico con actividad antagonista de ccr5 y produccion del mismo |
| HK1232147A1 (zh) * | 2014-03-21 | 2018-01-05 | Tobira Therapeutics, Inc. | 用於治疗纤维化的赛尼克韦罗 |
| BR112017004708A2 (pt) * | 2014-09-12 | 2017-12-05 | Tobira Therapeutics Inc | terapia de combinação de cenicriviroc para o tratamento de fibrose |
| JP6716568B2 (ja) * | 2014-12-23 | 2020-07-01 | トビラ セラピューティクス， インコーポレイテッド | セニクリビロックの製造方法及び関連類似体 |
| BR112017016388A2 (pt) * | 2015-02-10 | 2018-03-27 | Tobira Therapeutics, Inc. | cenicriviroc para o tratamento da fibrose |
| WO2016135740A1 (en) * | 2015-02-23 | 2016-09-01 | Natco Pharma Limited | Process for preparing stable oral compositions of everolimus |
| US20180360846A1 (en) * | 2015-09-16 | 2018-12-20 | Tobira Therapeutics, Inc. | Cenicriviroc combination therapy for the treatment of fibrosis |
| JP2019520427A (ja) | 2016-06-21 | 2019-07-18 | トビラ セラピューティクス， インコーポレイテッド | 精製されたセニクリビロク及びセニクリビロク製造のための精製された中間体 |
| US11045423B2 (en) | 2016-08-08 | 2021-06-29 | Hetero Labs Limited | Anti-retroviral compositions |
| MX2019002057A (es) | 2016-08-31 | 2019-11-18 | Tobira Therapeutics Inc | Formas solidas de mesilato de cenicriviroc y procesos para elaborar formas sólidas de mesilato de cenicriviroc. |
| US10736905B1 (en) | 2016-09-09 | 2020-08-11 | Shahin Fatholahi | Nefopam dosage forms and methods of treatment |
| JP7326161B2 (ja) | 2017-05-11 | 2023-08-15 | キング アブドラ ユニバーシティ オブ サイエンス アンド テクノロジー | 組織エンジニアリングおよびバイオプリンティングにおける使用のためのゲルを形成し得るペプチド |
| KR102418307B1 (ko) | 2017-05-11 | 2022-07-06 | 킹 압둘라 유니버시티 오브 사이언스 앤드 테크놀로지 | 미세유체공학-기반 3d 바이오프린팅용 장치 및 방법 |
| RU2662160C9 (ru) * | 2017-07-03 | 2018-10-22 | Александрович Иващенко Андрей | Комбинированный лекарственный препарат для терапии вирусных инфекций |
| US11446311B2 (en) | 2017-09-08 | 2022-09-20 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| US10736874B1 (en) | 2017-09-08 | 2020-08-11 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| WO2021133811A1 (en) * | 2019-12-26 | 2021-07-01 | Teva Pharmaceuticals International Gmbh | Solid state forms of cenicriviroc and process for preparation thereof |
| EP4093380A1 (en) | 2020-01-23 | 2022-11-30 | Lupin Limited | Pharmaceutical compositions of raltegravir |
| US12109327B2 (en) | 2020-08-20 | 2024-10-08 | King Abdullah University Of Science And Technology | Scaffolds from self-assembling tetrapeptides support 3D spreading, osteogenic differentiation and angiogenesis of mesenchymal stem cells |
| US11673324B2 (en) | 2020-08-20 | 2023-06-13 | King Abdullah University Of Science And Technology | Nozzle for 3D bioprinting |
| US12590121B2 (en) | 2020-08-20 | 2026-03-31 | King Abdullah University Of Science And Technology | Peptide compound with repetitive sequences |
| JP2022108727A (ja) * | 2021-01-13 | 2022-07-26 | 日曹商事株式会社 | フマル酸含有固形製剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2167649C2 (ru) * | 1995-08-11 | 2001-05-27 | Ниссан Кемикал Индастриз, Лтд. | Способ получения твердой дисперсии умеренно водорастворимого лекарственного вещества (варианты) и фармацевтическая композиция |
| AU9461898A (en) * | 1997-10-20 | 1999-05-10 | Dainippon Pharmaceutical Co. Ltd. | Stable drug composition |
| CA2244097A1 (en) * | 1998-08-21 | 2000-02-21 | Bernard Charles Sherman | Pharmaceutical composition comprising bupropion hydrochloride and fumaric acid |
| WO2000061109A1 (fr) * | 1999-04-12 | 2000-10-19 | Shionogi & Co., Ltd. | Procede de production de composition medicamenteuse renfermant un compose medicamenteux hydrophobe basique |
| WO2006059716A1 (ja) * | 2004-12-03 | 2006-06-08 | Takeda Pharmaceutical Company Limited | 固形製剤 |
| EP2552429A1 (en) * | 2010-04-02 | 2013-02-06 | Phivco-1 LLC | Combination therapy comprising a ccr5 antagonist, a hiv-1 protease inhibitor and a pharmacokinetic enhancer |
| HK1232147A1 (zh) * | 2014-03-21 | 2018-01-05 | Tobira Therapeutics, Inc. | 用於治疗纤维化的赛尼克韦罗 |
-
2014
- 2014-05-15 CN CN201480027717.3A patent/CN105263498B/zh active Active
- 2014-05-15 WO PCT/US2014/038211 patent/WO2014186581A1/en not_active Ceased
- 2014-05-15 SG SG10201708595YA patent/SG10201708595YA/en unknown
- 2014-05-15 SG SG11201509136YA patent/SG11201509136YA/en unknown
- 2014-05-15 CA CA2911212A patent/CA2911212A1/en not_active Abandoned
- 2014-05-15 KR KR1020157035069A patent/KR20160013068A/ko not_active Ceased
- 2014-05-15 RU RU2014150327A patent/RU2633069C2/ru active
- 2014-05-15 EP EP14797645.0A patent/EP2996694A4/en not_active Withdrawn
- 2014-05-15 BR BR112015028644A patent/BR112015028644A2/pt not_active Application Discontinuation
- 2014-05-15 AU AU2014265327A patent/AU2014265327B2/en not_active Ceased
- 2014-05-15 MX MX2015015500A patent/MX383706B/es unknown
- 2014-05-15 UA UAA201512359A patent/UA115807C2/uk unknown
- 2014-05-15 MY MYPI2015703958A patent/MY180145A/en unknown
- 2014-05-15 US US14/891,019 patent/US20160081985A1/en not_active Abandoned
- 2014-05-15 JP JP2016514093A patent/JP6391674B2/ja not_active Expired - Fee Related
-
2015
- 2015-11-02 IL IL242394A patent/IL242394B/en active IP Right Grant
- 2015-11-05 PH PH12015502539A patent/PH12015502539A1/en unknown
- 2015-11-13 CL CL2015003346A patent/CL2015003346A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016518452A5 (https=) | ||
| RU2014150327A (ru) | Композиции ценикривирока и способы их получения и применения | |
| RU2015110699A (ru) | Фармацевтическая антиретровирусная композиция | |
| KR102058097B1 (ko) | 다루나비어 복합 제제 | |
| JP2006516570A5 (https=) | ||
| JP2019516674A5 (https=) | ||
| US10842751B2 (en) | Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine | |
| JP2015521191A5 (https=) | ||
| CA2779052A1 (en) | Pharmaceutical composition of entecavir and process of manufacturing | |
| US9757340B2 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| EP3326619B1 (en) | Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine | |
| KR20160060764A (ko) | 아타자나비르 및 코비시스타트의 ｈｉｖ 치료 제제 | |
| AU2016231883B2 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| KR20150083255A (ko) | 둘록세틴이 함유된 안정한 다중코팅 정제 조성물 | |
| JP2015221782A (ja) | モンテルカストナトリウム含有製剤 | |
| EP3496719B1 (en) | A multi-class anti-retroviral composition | |
| US20150141376A1 (en) | Pharmaceutical compositions of anti-viral compounds and process for preparation thereof | |
| EP3383402B1 (en) | Pharmaceutical composition comprising darunavir and method for the preparation thereof | |
| JP5910311B2 (ja) | 医薬錠剤およびその製造方法 | |
| WO2018029566A1 (en) | A high drug loaded tablet composition for treating hiv | |
| HK40114875A (en) | Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine | |
| AU2024357464A1 (en) | Pharmaceutical compositions containing doravirine and islatravir | |
| EA043966B1 (ru) | Твердая фармацевтическая композиция на основе тикагрелора для перорального применения |